Uses of Furixat

Furixat is commonly used to improve symptoms related to the urinary tract and genitals. So how is Furixat used? The following article will provide the necessary information for readers to use the drug safely and effectively.

Furixat belongs to the group of drugs that support the treatment of urinary tract diseases with the main ingredient being the active ingredient Flavoxate hydrochloride 200mg and is made in the form of film-coated tablets. Pharmacodynamics: Flavoxate is an antispasmodic agent that directly antagonizes the smooth muscle contractions of the bladder and genitourinary tract. Is a papaverine-like smooth muscle relaxant. But the antispasmodic effect is stronger and the toxicity is less than the alkaloids than the opiates. Flavoxate's mechanism of action is a combination of myotropic, local anesthetic, and calcium antagonists. Flavoxate is a direct relaxant of smooth muscle, probably due to its phosphodiesterase inhibitory effect and calcium resistance.
Pharmacokinetics: After oral administration, Flavoxate reaches peak concentrations within 20 minutes. The drug is distributed low in brain tissue but high in liver, kidney and bladder. Its major metabolite is 3 methylflavone-8-carboxylic acid. After 12 hours of oral administration, approximately 55% of the drug is excreted as MFCA and/or conjugated metabolites in the urine. Flavoxate is completely eliminated.

Furixat drug is used in the following cases:
Used to relieve symptoms in: Difficulty urinating, urinary urgency, nocturia, urinary frequency and interruption in pathologies of the bladder, prostate such as inflammation of the prostate gland. bladder, bladder pain, urethritis, prostatitis, urethritis-triangulitis. Support in antispasmodic treatment in diseases such as: kidney and ureteral stones, urinary tract spasm disorders caused by catheterization and cystoscopy and in sequelae of lower urinary tract surgery. Relieves spasms in the female genital tract such as: pelvic pain, dysmenorrhea, hypertonia and uterine motility disorders. Contraindications:
Patients with a history of allergy to any component of the drug Furixat. The patient has the following obstructive conditions: ileal or duodenal obstruction, non-dilated bowel, trauma causing intestinal obstruction or paralytic ileus, gastrointestinal bleeding.

Each time take 1 tablet of 200mg, use 3-4 tablets / day.
Furixat is quickly absorbed into the body and has an effective effect. The likelihood of an effective response to medication depends on the nature and severity of the symptoms diagnosed and the patient's overall condition. The therapeutic effects on the bladder muscle system will appear within 2-3 hours.
In patients with an infectious state, treatment is usually prolonged in addition to anti-infective agents (ie, 1 week or more).
In case the patient has chronic symptoms in the bladder, it is advisable to maintain the medication for the best results. As symptoms improve over time, a dose reduction should be considered.

Overdosage: Patients with an overdose of Furixat should have gastric lavage within 4 hours of dosing. If the degree of overdose is quite severe or the gastric lavage is delayed, treatment with drugs of the parasympathetic group should be treated. Missed dose: Take the dose as soon as you remember. However, if the interval between the next dose is too short, skip the missed dose and continue taking it as scheduled. Do not take a double dose to make up for a missed dose.

Some rare side effects include: Nausea and vomiting (usually not when taken on a full stomach), dry mouth, dizziness, headache, drowsiness (usually goes away with dose reduction or medication). distance), emotional instability, eye accommodation disorder, glaucoma, urticaria or other skin diseases, confusion especially in adults, urinary disturbance, tachycardia, fever, increased eosinophils and can cause constipation at high doses.

Precautions for use:
Patients with concurrent urogenital tract infections should take flavoxate hydrochloride in combination with appropriate antibiotic therapy. Furixat should be used with caution in patients with glaucoma, severe obstruction of the lower urinary tract due to compression. Effects on Ability to Drive or Use Machines: Patients who operate vehicles or machines or engage in tasks requiring attention should be warned about possible side effects such as blurred vision and dizziness. eye. Pregnant women: Care should be taken when taking the drug in case of pregnancy, especially in the first 3 months of pregnancy. Use of Furixat in children: This drug should not be used in children under 12 years of age because there are no studies to confirm the safety level for this age group. Storage:
The medicine should be kept in a dry place, the temperature should not exceed 30 degrees Celsius, avoid direct sunlight. Above is all information about the uses and precautions when using Furixat. Patients need to carefully read the instructions for use, strictly follow the indications and dosage, consult the doctor to achieve the best treatment effect.